Skip to content

Epicondylar Muscle Activation in Tennis Players

Effectiveness of Electrical Dry Needdling on Epicondylar Muscle Activation by EMG in Tennis Players. Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06160011
Enrollment
48
Registered
2023-12-07
Start date
2023-12-01
Completion date
2024-08-31
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epicondylitis, Lateral

Keywords

Electrical dry needling, EMG, Tennis, Physiotherapy

Brief summary

Epicondylitis is one of the most common pathologies in tennis players. The search for an effective treatment is necessary for the relief of symptoms and the return to sports practice. Therefore, a ddry needling treatment in combination with electricity is postulated as an alternative to isolated dry needling treatment or conventional physiotherapy treatment. Data will be collected in relation to pain and muscle activation by EMG in order to check the effectiveness of these techniques as well as the muscle activation that is generated.

Interventions

OTHERElectrical dry needling + Conventional physiotherapy

Electrical dry needling and conventional physiotherapy treatment (massage, pressure release): 2 sessions

OTHERDry needling + Conventional physiotherapy

Dry needling and conventional physiotherapy treatment (massage, pressure release): 2 sessions

OTHERConventional physiotherapy

Conventional physiotherapy treatment (massage, pressure release): 2 sessions

Sponsors

University of Salamanca
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* tennis players of both sexes * federated and non-federated of Castilla y León * playing tennis for at least 2 years * presence if one trigger point in epicondilar musculature

Exclusion criteria

* not informed consent signature * nervous, vascular, articular or musculoskeletal system alterations * tests or techniques performed fear (belonephobia) * pregnancy * allergic to any type of metal or body oil * active febrile proces * current pain treatments in the area involved * surgery in the last year for upper limb pathologies * cognitive alterations * taking painkillers or anti-inflammatory drugs 24 hours before the start of the study or taking them during the duration of the study

Design outcomes

Primary

MeasureTime frameDescription
Muscular activation30 minutesElectromyography: the adequate electrical activity of the muscles will be observed and the nerves will show adequate conduction of electrical impulses. This indicates normal and healthy functioning of the neuromuscular system
Subjective PainInitial, up to 2 weeks, and up to 6 weeksNumeric Pain Rating Scale: Single 11-point numerical scale where scores correspond to Pain scores are interpreted as: 0 = no pain, 1-3 = mild pain, 4-6 = moderate pain and 7-10 = severe pain. 7-10 = severe pain
AlgometryInitial, up to 2 weeks, and up to 6 weeksPressure algometer is an instrument with a circular disk on which the pressure measurements are displayed (with a range of 5 kg, divided into 10 parts of half a kilogram), and a rubber tip with a circular surface of 1 cm2, which allows transferring the pressure force to deep tissues.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026